Kari Syrjänen, Sanni Rinne, Nea Koskela, Birgitta Michels, Julia Butt, Seija Grénman, Tim Waterboer, Stina Syrjänen, Karolina Louvanto
{"title":"Helicobacter pylori (Hp) multiplex serology and its dynamics within families during a three-year prospective follow-up.","authors":"Kari Syrjänen, Sanni Rinne, Nea Koskela, Birgitta Michels, Julia Butt, Seija Grénman, Tim Waterboer, Stina Syrjänen, Karolina Louvanto","doi":"10.1016/j.ijid.2025.107893","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Transmission routes of Helicobacter pylori (Hp) have been extensively studied, but many aspects remain unclear. This study explored the dynamics of multiplex Hp-serology within regular families during a 36-month prospective follow-up.</p><p><strong>Methods: </strong>Altogether 329 families from the Finnish Family HPV (FFHPV)-study were subjected to sequential blood sampling and now tested also for six Hp-proteins; HP0010, HP0073, HP0547, HP0875, HP0887, and HP1564 using Multiplex serology assay.</p><p><strong>Results: </strong>Hp-seropositivity, as defined by being seropositive to at least 3 of the 6 Hp proteins, was more common among the fathers (20%) than mothers (10%). After maternal antibody decay, only few children tested Hp-seropositive at later follow-up visits, indicating that acquisition of Hp-infection is practically non-existent (0.4% to 2.0%) at an early age. No evidence was found to support the person-to-person transmission of Hp in this cohort, as there was no correlation in Hp-seropositivity or antibody levels between the spouses and/or their offspring, and Hp-seropositive individuals did not seem to increase the risk of other family members to co-test Hp-seropositive.</p><p><strong>Conclusion: </strong>Our results perfectly agree with a recently published register-linkage study from Finland, where Hp and Hp-related co-morbidity are predicted to disappear among the native Finns during the 21<sup>st</sup> century.</p>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":" ","pages":"107893"},"PeriodicalIF":4.8000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2025.107893","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Transmission routes of Helicobacter pylori (Hp) have been extensively studied, but many aspects remain unclear. This study explored the dynamics of multiplex Hp-serology within regular families during a 36-month prospective follow-up.
Methods: Altogether 329 families from the Finnish Family HPV (FFHPV)-study were subjected to sequential blood sampling and now tested also for six Hp-proteins; HP0010, HP0073, HP0547, HP0875, HP0887, and HP1564 using Multiplex serology assay.
Results: Hp-seropositivity, as defined by being seropositive to at least 3 of the 6 Hp proteins, was more common among the fathers (20%) than mothers (10%). After maternal antibody decay, only few children tested Hp-seropositive at later follow-up visits, indicating that acquisition of Hp-infection is practically non-existent (0.4% to 2.0%) at an early age. No evidence was found to support the person-to-person transmission of Hp in this cohort, as there was no correlation in Hp-seropositivity or antibody levels between the spouses and/or their offspring, and Hp-seropositive individuals did not seem to increase the risk of other family members to co-test Hp-seropositive.
Conclusion: Our results perfectly agree with a recently published register-linkage study from Finland, where Hp and Hp-related co-morbidity are predicted to disappear among the native Finns during the 21st century.
期刊介绍:
International Journal of Infectious Diseases (IJID)
Publisher: International Society for Infectious Diseases
Publication Frequency: Monthly
Type: Peer-reviewed, Open Access
Scope:
Publishes original clinical and laboratory-based research.
Reports clinical trials, reviews, and some case reports.
Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases.
Emphasizes diseases common in under-resourced countries.